TET1 and metabolic dysfunction-associated steatotic liver disease: Nevertheless, aspartate aminotransferase (AST) and alanine transaminase (ALT) enzymatic activity assays, the liver functional studies demonstrated that TET1 KO substantially alleviated liver damages in the HFD-induced MASLD progression (Fig. 2E,F).